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Abstract
Introduction: In the ICU, peripherally inserted central catheters (PICCs) may be an alternative option to standard
central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits
of PICCs (such as low flow rates) may be overcome with the use of power-injectable catheters.
Methods: We retrospectively reviewed all of the power-injectable PICCs inserted in adult and pediatric patients in
the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance.
Results: We collected 89 power-injectable PICCs (in adults and in children), both multiple and single lumen. All
insertions were successful. There were no major complications at insertion and no episodes of catheter-related
bloodstream infection. Non-infective complications during management were not clinically significant. There was
one episode of symptomatic thrombosis during the stay in the ICU and one episode after transfer of a patient to a
non-intensive ward.
Conclusion: Power-injectable PICCs have many advantages in the ICU: they can be used as multipurpose central
lines for any type of infusion including high-flow infusion, for hemodynamic monitoring, and for high-pressure
injection of contrast media during radiological procedures. Their insertion is successful in 100% of cases and is not
associated with significant risks, even in patients with coagulation disorders. Their maintenance is associated with
an extremely low rate of infective and non-infective complications.
Introduction
The use of peripherally inserted central catheters
(PICCs) has many theoretical advantages in the ICU set-
ting because these devices are associated with low-risk
insertion, even in patients with altered coagulation and/
or difficult neck anatomy [1]. PICC insertion can be car-
ried out with no risk of pleura-pulmonary damage and
with no clinically significant risk of local hemorrhage or
hematoma, if compared with standard central venous
catheters (CVCs) [2]. Furthermore, PICC insertion in
the upper mid-arm is characterized by an easy dressing
of the exit site, this benefit being particularly evident in
patients with tracheostomy [3]. Although the issue is
somehow controversial [4,5], PICCs are also usually
considered a device at low risk for catheter-related
bloodstream infection (CRBSI), which may be an addi-
tional advantage in acutely ill patients [2]. PICCs can
also be used for central venous pressure monitoring [6],
specifically when using polyurethane, open-ended cathe-
ters > 4 Fr, as long as they have no evidence of
malfunction.
Although the potential benefit of PICCs in the acutely
ill patient was proposed almost 10 years ago [7], some
technical limitations have slowed their introduction into
clinical practice in the ICU. The ICU patient usually
requires high flow rates of intravenous infusion as well
as simultaneous administration of potentially incompati-
ble drugs, which should ideally be delivered through
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multiple-lumen catheters. Since standard PICCs are
catheters with small caliber (typically, 4 to 5 Fr) and
relevant length (30 to 40 cm on average), they are asso-
ciated with a high resistance to flow. A single-lumen 4
Fr PICC may achieve a flow rate of 2 to 3 ml/minute
(by gravity infusion) and 10 to 11 ml/minute (with
pump); the flow rates of a single-lumen 5 Fr PICC are
only slightly higher (3 to 4 ml/minute by gravity and 11
to 13 ml/minute with pump). Double-lumen PICCs have
worse performance in terms of flow, because increasing
the number of lumens reduces the lumen size and
further decreases the flow rate.
The situation changed following the recent develop-
ment of PICCs made of ultra-resistant polyurethane,
which were originally introduced for use with the high-
pressure pumps (so-called power injectors) commonly
utilized for high-velocity infusion of contrast media dur-
ing computed tomography scan and other radiological
procedures. The rationale for these so-called power-
injectable PICCs was the concern of potential mechani-
cal damage to standard polyurethane and silicon PICCs
when used during high-pressure injection. Power injec-
tors may develop pressures as high as 300 psi (silicone
catheters tolerate no more than 50 to 60 psi, and most
polyurethane catheters approximately 100 psi). Several
reports of mechanical damage to PICCs and other
devices have been described in the literature, leading to
an official warning from the US Food and Drug Admin-
istration [8] - which recommended that power injection
should be done exclusively through venous access
devices specifically registered for this use.
Such power-injectable PICCs - developed and mar-
keted by several companies - have been shown to have
the additional advantage of delivering infusions at a very
high rate (3 to 5 ml/second = 180 to 300 ml/minute), if
coupled with an appropriate infusion pump. Multiple-
lumen PICCs were also developed shortly thereafter,
and their use in the ICU started to spread. At present,
several brands of power-injectable PICCs are available -
single lumen (3, 4 or 5 Fr), double lumen (4 or 5 Fr)
and triple lumen (6 Fr). They all share several features
that make them particularly attractive for the ICU set-
ting: low risk of mechanical and hemorrhagic complica-
tions at insertion, low risk of CRBSI, high flow (up to
300 ml/minute), easy monitoring of central venous pres-
sure, low risk of lumen obstruction, and safe use for
radio-diagnostic procedures. Most power-injectable
PICCs also have a reverse-taper design at the proximal
end; that is, the diameter of the catheter that enters the
exit site is slightly thicker than the diameter of the rest
of the catheter. This technical feature is potentially asso-
ciated with reduced bleeding at the exit site soon after
insertion, with increased stability of the PICC (reduced
risk of dislodgement) and with protection against exit
site contamination.
In the present paper, we report our preliminary
experience with the use of power-injectable PICCs in
adult and pediatric ICU patients.
Materials and methods
We reviewed retrospectively all power-injectable PICCs
inserted in acutely ill patients admitted to the shock/
trauma ICU and the pediatric ICU of our institution (a
1,100-bed university hospital), during 12 months.
According to our hospital policies, indications for
PICC insertion were (a) need for a central line for par-
enteral nutrition, and/or infusion of drugs that require a
central line (pH < 5 or > 9, osmolarity > 500 mOsm/l,
drugs associated with endothelial damage), and/or (b)
central venous pressure monitoring, and/or (c) need for
frequent blood sampling. Need for a central line with
more than three lumens was considered a clear indica-
tion for a standard multiple-lumen CVC. Also, all
PICCs were inserted as an elective procedure; all central
lines inserted in emergency were standard CVCs. Overt
sepsis was also considered a contraindication to PICC
insertion. Other standard contraindications to PICC
insertion, according to our hospital policies, were small
deep veins of the arm (brachial/basilic vein < 4 mm),
local contraindications due to specific arm conditions
(skin infection, burns, orthopedic devices blocking the
arm, previous axillary node resection due to breast can-
cer surgery, and so forth) as well as actual or impending
chronic renal failure requiring an arteriovenous fistula.
Severe arm edema and/or obesity are not considered
contraindications to PICC insertion, although in these
situations the brachial and basilic vein might be too
deep ( > 3 cm) so the cephalic vein is preferentially
cannulated.
We considered both multiple-lumen and single-lumen
catheters, of different sizes (from 4 to 6 Fr) and different
brands, as long as they were power injectable and were
inserted during the ICU stay (Figures 1 and 2). All
PICCs were inserted according to the specific protocol
defined by our hospital PICC team [9]. All of the cathe-
ters were inserted by ultrasound-guided puncture of the
deep veins in the upper mid-arm (Figure 3), as recom-
mended by current guidelines [3,10], using the micro-
introducer technique. A standard 5 to 10 MHz linear
ultrasound probe (adult patients) or a small 10 to 14
MHz hockey-stick ultrasound probe (children) was used.
Veins with diameter = or > 4 mm were considered sui-
table for 4 Fr catheters, veins = or > 5 mm suitable for
5 Fr catheters and veins = or > 6 mm suitable for 6 Fr
catheters. Maximal barrier precautions were consistently
used during the procedure (cap, mask, sterile gown,
Pittiruti et al. Critical Care 2012, 16:R21
http://ccforum.com/content/16/1/R21
Page 2 of 7
Figure 1 Triple-lumen power-injectable peripherally inserted central catheter inserted in an adult patient in the ICU.
Figure 2 Double-lumen power-injectable peripherally inserted central catheter inserted in a pediatric patient in the ICU.
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sterile gloves, vast sterile field). The correct position of
the tip of the catheter (that is, in proximity of the junc-
tion between the superior vena cava and the right
atrium) was verified during the procedure using the
intracavitary electrocardiography (EKG) method [11]; a
post-procedural chest X-ray for checking the tip posi-
tion was required only when the EKG method was not
applicable (atrial fibrillation and/or no evident P-wave at
the basal EKG). All PICCs were secured to the skin
using sutureless devices, as currently recommended
[12-14]. All procedures were performed by nurses or
physicians specifically trained for PICC insertion. Main-
tenance of the line and dressing policies were carried
out according to the intervention bundle for preventing
line infections developed by the GAVeCeLT - Gruppo
Accessi Venosi Centrali a Lungo Termine - and adopted
by our hospital PICC team (preferential use of 2% chlor-
hexidine for antisepsis of the exit site, preferential use of
transparent dressing, and so forth) [15]. Occlusion of
the line was prevented by a specified policy of periodic
flushing and locking with saline.
Acutely ill pediatric patients were also included in the
study. Since 3 Fr power-injectable PICCs were not yet
available in Italy at that time, power-injectable PICCs
could be inserted in children only when an arm vein > 4
mm was available. In many acutely ill children, power-
injectable PICCs had been inserted as direct central
lines, by ultrasound-guided puncture of the internal
jugular vein or of the brachio-cephalic vein, or as access
to the inferior vena cava, by ultrasound-guided puncture
of the femoral vein: all of these off-label uses of power-
injectable PICCs were excluded from this analysis (only
PICCs inserted into the upper mid-arm were
considered).
According to our hospital policies, diagnosis of CRBSI
was established by the differential time to positivity
method (blood culture from the catheter becoming posi-
tive at least 120 minutes before the peripheral blood
culture) or by direct culture of the tip of the catheter,
should the catheter be removed or replaced over guide-
wire (culture of the same microorganism from the blood
and from the tip of the catheter).
Diagnosis of catheter-related thrombosis was estab-
lished by ultrasound examination (compression ultraso-
nography and duplex Doppler), performed only when
clinically indicated by signs and symptoms suggesting
venous occlusion (edema of the arm, PICC malfunction,
unexplained local pain, and so forth). Catheter-related
Figure 3 Ultrasound scan at the mid-arm. Left to right: basilic vein, brachial nerve, and brachial artery between two small brachial veins.
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peripheral venous thrombosis was defined as the pre-
sence of occlusive thrombosis of the deep veins of the
arm containing the PICC, extending or not to the axil-
lary vein. Catheter-related central venous thrombosis
was defined as the presence of any extent of thrombosis
in the subclavian, internal jugular or brachio-cephalic
vein or in the superior vena cava on the side of PICC
insertion.
We collected all relevant data and information, includ-
ing patient’s age and disease, indication for PICC inser-
tion, duration of the dwell time for the device, incidence
of complications at insertion or during maintenance,
and cause of removal. All data were included in a soft-
ware-operated database and analyzed by standard
descriptive statistics. Values are reported as the mean ±
standard deviation.
According to the policy of our hospital, retrospective
studies do not require approval from the Ethics Com-
mittee and do not require informed consent from the
patient. Informed consent was obtained, however, from
the patients represented in Figures 1 and 2 for publica-
tions of their images.
Results
During the study period, 89 open-ended, power-inject-
able polyurethane PICCs were inserted in our ICUs.
Sixty-five catheters were inserted in adult patients (50
triple-lumen 6 Fr, six double-lumen 5 Fr and nine sin-
gle-lumen 4 Fr) and 24 catheters in pediatric patients
(15 double-lumen 5 Fr, two double-lumen 4 Fr and
seven single-lumen 4 Fr).
All PICCs were successfully inserted without major
complications. Minor complications at insertion were
local hematoma (three cases, 3.4%), repeated punctures
of the vein (five cases, 5.6%), difficulty in progression of
the catheter (four cases, 4.5%), and one malposition
(one patient with no evident P-wave on basal EKG,
where the intracavitary EKG method could not be used).
This latter case required repositioning of the PICC by
exchange over guidewire. A few adult patients had
severe obesity (body mass index > 35, seven patients); in
these patients PICCs were inserted without difficulty,
mostly via the cephalic vein since brachial and basilica
veins were too deep.
The average dwell time of the device in the ICU was
25 ± 12 days (median value 22 days): most catheters
stayed in place for > 2 weeks and were removed when
the patient was transferred to a non-intensive ward. No
PICC was removed because of complications while in
the ICU. One patient died while the PICC was still
indwelling. In a few cases of adult patients, the PICC
was left in place even after discharge from the ICU.
Most PICCs were used easily for high-flow intrave-
nous infusions ( > 1,000 ml/hour, by infusion pump), as
well as for measurement of the central venous pressure.
In almost one-half of patients, PICCs were also used for
injection of contrast medium during computed tomo-
graphy scans. There were no relevant episodes of occlu-
sion or of persistent difficulty in blood withdrawal; eight
cases of partial obstruction were resolved by simple sal-
ine infusion under pressure. There was not a single case
of CRBSI. Symptomatic catheter-related central venous
thrombosis occurred only in one adult in the ICU (a
patient with a hematological neoplastic disease, admitted
to the ICU for respiratory failure); a second case
occurred in a patient after his transfer to a non-inten-
sive ward. Both episodes occurred within 10 days after
PICC insertion. There were no dislodgements or acci-
dental removals of the device while the patients were in
the ICU; one case of accidental removal occurred after
transfer of the patient to a non-intensive ward.
Discussion
The first clinical experience with PICCs in the ICU was
reported in 1996 [16]. At that time PICC insertion was
usually performed at the antecubital fussa, without ultra-
sound guidance, but the results of this experience were
particularly promising - especially in terms of minimal
incidence of CRBSI (91 PICCs, 0.6 episodes per 1,000
catheter-days). The potential advantages of PICCs in the
ICU have been described by other authors [7]; however,
reports dealing specifically with the use of power-inject-
able PICCs [17,18], and particularly of power-injectable
PICCs in the ICU [19], are scarced. To our knowledge,
the present paper is the first clinical study reporting a
detailed analysis of the complications associated with
the use of power-injectable PICCs in adult and pediatric
patients in the ICU.
Our rate of complications at insertion has been extre-
mely low, especially considering the anatomical difficul-
ties expected in acutely ill patients. Complications at
insertion are known to be minimal when using both
ultrasound guidance and the micro-introducer technique
[2,10,20,21].
With regards to the incidence of CRBSI, evidence is
accumulating that PICCs are associated with a lower
rate of infection if compared with CVCs, probably
because of an exit site that is less prone to contamina-
tion (upper mid-arm skin is characterized by a lower
bacterial colonization if compared with skin at the neck
or in the infra-clavicular area) [2,3]. This lower infection
rate has also been shown in ICU patients. In a 2008
multicenter study including eight Spanish ICUs, the
CRBSI rate of PICCs was significantly lower than that of
CVCs (1.08 episodes vs. 3.83 episodes for 1,000 cathe-
ter-days), although ultrasound guided insertion was not
used [22]. In a recent study carried out regarding 37
PICCs in a burn unit [23] the incidence of PICC-related
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bloodstream infection was 0 episodes, as compared with
6.6 episodes of CVC-related bloodstream infection for
1000 catheter-days. In another study in a surgical ICU
[24], PICCs presented 2.2 episodes of CRBSI per 1,000
catheter-days versus 6 episodes in CVCs. Even in a
recent clinical study [19], which reported a high inci-
dence of PICC-related thrombosis (see below), there was
not one episode of CRBSI in a cohort of 50 PICCs con-
secutively inserted into ICU patients. According to
another recent paper in ICU patients [25], the occur-
rence of CRBSI appears to happen later in PICCs com-
pared with CVCs (23 days vs. 13 days). As reported in
similar papers on ICU patients [19,23], in our experi-
ence the rate of CRBSI was zero - although it must be
stressed that our investigation was a noncontrolled ret-
rospective study and did not aim to compare CVCs with
PICCs in terms of infection rate.
Mechanical complications were also uncommon in
our series. Dislodgement has been described as a pro-
blem only in studies not using ultrasound-guided inser-
tion in the upper mid-arm and/or not using sutureless
devices for PICC securement [16]. Also, mechanical
damage such as ruptures usually occurs with silicon
PICCs rather than with polyurethane PICCs [21]. The
ultraresistant polyurethane of power-injectable PICCs
appears to protect from mechanical damage, dislodge-
ment and occlusion. In a recent clinical study [18], a
decreased risk of occlusion and rupture was reported
with power-injectable PICCs if compared with silicon
and standard polyurethane PICCs.
A high incidence of clinically symptomatic PICC-
related thrombosis has been recently reported by two
papers, one dealing with non-power-injectable PICCs in
the ICU [26] and the other with triple-lumen 6 Fr
power-injectable PICCs in the ICU [19]. These findings
are in contrast with the low incidence of symptomatic
thrombosis reported by our present study and by a
recent study of a series of 473 power-injectable PICCs
[17]. This apparent contradiction may be explained by
the observation that PICC-related venous thrombosis is
known to be secondary to many different factors [2],
including the use of ultrasound guidance during inser-
tion, the choice of vein (the diameter of the vein should
be at least three times the diameter of the PICC), the
proper position of the tip, as well as the material of the
catheter and the use of sutureless devices for secure-
ment. The low rate of symptomatic PICC-related throm-
bosis in our study may thus be explained by the
consistent use of ultrasound guidance, by the careful
choice of a vein of an appropriate diameter, by the
intra-procedural verification of the position of the tip by
the intracavitary EKG method, as well as by the use of a
sutureless securement device in 100% of cases. On the
contrary, in the papers quoted above, the same catheter
size - either 5 Fr [26] or 6 Fr [19] - was adopted in
every patient.
Conclusions
This preliminary retrospective report shows that power-
injectable PICCs can be successfully utilized in most
ICU patients, even in those requiring high volumes of
fluids, multiple intravenous lines and/or monitoring of
the central venous pressure, as well as in children. Con-
traindications to PICC insertion are few, such as the
need for an emergency central line, need for a central
line with more than three lumens, and lack of availabil-
ity of a vein > 4 mm in the upper mid-arm. CRBSI and
catheter-related venous thrombosis appear to be uncom-
mon. Most early and late complications can be success-
fully minimized by the adoption of an insertion protocol
[27] including key recommendations such as ultrasound
guidance, by the choice of a vein with appropriate cali-
ber, by careful positioning the tip by the EKG method,
and by the consistent use of sutureless securement
devices.
Considering the results of this preliminary retrospec-
tive analysis, further prospective, controlled, randomized
trials comparing the clinical outcome of CVCs with
PICCs in intensive care patients are warranted.
Key messages
• Power-injectable PICCs are a promising alternative
option to standard CVCs in ICU patients.
• Power-injectable PICCs may have a role in many
ICU patients, with few contraindications (emergency,
need for more than three lumens, small deep veins
of the arm, or local contraindications to brachial/
basilic venipuncture).
• If inserted with a proper protocol (including ultra-
sound guidance, proper choice of vein, EKG gui-
dance, aseptic technique, securement with sutureless
device, and so forth), the insertion of PICCs is not
associated with any relevant risk, even in patients
with severe cardiorespiratory problems.
• If inserted with a proper protocol (see above), the
risk of catheter-related infection is similar to or even
lower than that with CVCs.
• If inserted with a proper protocol (see above), the
risk of catheter-related thrombosis is similar to that
with CVCs.
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